search
Back to results

Chocolate Consumption in Healthy Pregnant Women Trial

Primary Purpose

Hypertension Pregnancy-induced

Status
Completed
Phase
Phase 2
Locations
Canada
Study Type
Interventional
Intervention
Flavanol-rich dark chocolate
Placebo Chocolate
Sponsored by
Laval University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Hypertension Pregnancy-induced focused on measuring Cacao, Chocolate, Theobromine, Flavonoids, Pregnant women, Hypertension pregnancy-induced, Pre-eclampsia, Epicatechin

Eligibility Criteria

18 Years - 35 Years (Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • non-smoking normotensive women aged from 18 to 35 years, between the 7 and 12 weeks of gestation (documented by ultrasound) and having a live fetus confirmed by fetal heart auscultation

Exclusion Criteria:

  • Patients with family history of premature cardiovascular disease
  • Chronic hypertension
  • Currently or previously use of medications interfering with glucose or lipids metabolism.
  • Use of supplements or natural health products that interfere with blood pressure.
  • Consumption of 1 or more alcohol drink per day.
  • Allergy or intolerance to nuts or chocolate.

Sites / Locations

  • Laval University, Department of Medicine, Institut des nutraceutiques et des aliments fonctionnels

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Dark chocolate

Placebo chocolate

Arm Description

Outcomes

Primary Outcome Measures

Changes in endothelial function and blood pressure

Secondary Outcome Measures

Changes from baseline in plasma flavanol and methylxanthines(caffeine, theobromine and theophylline) concentrations at 12 weeks
Weight change from baseline at 12 weeks
Number of participants with digestive and other signs and symptoms (nausea, abdominal pain, constipation, and headache)

Full Information

First Posted
July 31, 2012
Last Updated
August 2, 2012
Sponsor
Laval University
search

1. Study Identification

Unique Protocol Identification Number
NCT01659060
Brief Title
Chocolate Consumption in Healthy Pregnant Women Trial
Official Title
Assessment of Blood Pressure and Endothelial Function Pregnancy After Acute and Daily Consumption Flavanol-rich Chocolate Among Healthy Pregnant Women: a Pilot Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
August 2012
Overall Recruitment Status
Completed
Study Start Date
July 2008 (undefined)
Primary Completion Date
April 2009 (Actual)
Study Completion Date
April 2009 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Laval University

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to to test the feasibility of design methods and procedures for later use on a larger scale and to examine the acute and chronic effect of consumption of flavanol-rich chocolate on endothelium function and blood pressure in healthy pregnant women.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension Pregnancy-induced
Keywords
Cacao, Chocolate, Theobromine, Flavonoids, Pregnant women, Hypertension pregnancy-induced, Pre-eclampsia, Epicatechin

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
44 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Dark chocolate
Arm Type
Experimental
Arm Title
Placebo chocolate
Arm Type
Placebo Comparator
Intervention Type
Other
Intervention Name(s)
Flavanol-rich dark chocolate
Other Intervention Name(s)
Chocolate rich in flavanols
Intervention Description
The primary objective of this pilot RCT is to test the feasibility of design methods and procedures for later use on a larger scale. The secondary objective is to examine the acute and chronic effect of dark chocolate on endothelial function and blood pressure, among healthy pregnant women.
Intervention Type
Other
Intervention Name(s)
Placebo Chocolate
Other Intervention Name(s)
Flavanol-free chocolate
Intervention Description
Placebo intervention
Primary Outcome Measure Information:
Title
Changes in endothelial function and blood pressure
Time Frame
within the first 12 weeks of chocolate intake (week 12 and baseline)
Secondary Outcome Measure Information:
Title
Changes from baseline in plasma flavanol and methylxanthines(caffeine, theobromine and theophylline) concentrations at 12 weeks
Time Frame
within the first 12 weeks of chocolate intake (week 12 and baseline)
Title
Weight change from baseline at 12 weeks
Time Frame
within the first 12 weeks of chocolate intake (week 12 and baseline)
Title
Number of participants with digestive and other signs and symptoms (nausea, abdominal pain, constipation, and headache)
Time Frame
within the first 12 weeks of chocolate intake (week 12 and baseline)

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
35 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: non-smoking normotensive women aged from 18 to 35 years, between the 7 and 12 weeks of gestation (documented by ultrasound) and having a live fetus confirmed by fetal heart auscultation Exclusion Criteria: Patients with family history of premature cardiovascular disease Chronic hypertension Currently or previously use of medications interfering with glucose or lipids metabolism. Use of supplements or natural health products that interfere with blood pressure. Consumption of 1 or more alcohol drink per day. Allergy or intolerance to nuts or chocolate.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sylvie Dodin, MD
Organizational Affiliation
Laval University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Laval University, Department of Medicine, Institut des nutraceutiques et des aliments fonctionnels
City
Québec
State/Province
Quebec
ZIP/Postal Code
G1V 0A6
Country
Canada

12. IPD Sharing Statement

Citations:
PubMed Identifier
23565841
Citation
Mogollon JA, Bujold E, Lemieux S, Bourdages M, Blanchet C, Bazinet L, Couillard C, Noel M, Dodin S. Blood pressure and endothelial function in healthy, pregnant women after acute and daily consumption of flavanol-rich chocolate: a pilot, randomized controlled trial. Nutr J. 2013 Apr 8;12:41. doi: 10.1186/1475-2891-12-41.
Results Reference
derived

Learn more about this trial

Chocolate Consumption in Healthy Pregnant Women Trial

We'll reach out to this number within 24 hrs